1.
A real‑world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for Paxlovid and Molnupiravir. Human Biology. 2024;94(2):572-580. Accessed October 27, 2026. https://www.thehumbiol.org/Home/article/view/52